Skip to main content
Top
Published in: Malaria Journal 1/2020

01-12-2020 | Falciparum Malaria | Research

Assessment of platelet indices and platelet activation markers in children with Plasmodium falciparum malaria

Authors: Renate Asare, Clement Opoku-Okrah, Kwabena Owusu Danquah, Ohene Opare-Sem, Otchere Addai-Mensah, Daniel Gyamfi, Francis Agyei Amponsah, Edward Y. Afriyie, Richard Vikpebah Duneeh, David Ntiamoah Ofosu, Michael Frimpong

Published in: Malaria Journal | Issue 1/2020

Login to get access

Abstract

Background

Plasmodium falciparum malaria remains one of the world’s major infectious diseases that cause most morbidity and mortality, particularly in children. In Ghana, most children below the ages of 5 years depending on the severity of the infection often lose their lives. However, it is still debatable why infection with falciparum malaria contributes to thrombocytopenia.

Methods

This study sought to investigate the expression of the various platelet indices and activation markers in children with falciparum malaria. Platelet indices (Platelet count [PLT], Plateletcrite [PCT], Mean Platelet Volume [MPV], Platelet Distribution Width [PDW] and Platelet-Large Cell Ratio [P-LCR]) and platelet surface membrane glycoproteins (GPIIb/IIIa [PAC-1], P-selectin [CD62p] and GPIV [CD36]) expressions were determined in children with falciparum malaria (cases) and healthy children (controls) using automated blood cell analysis and flow cytometry techniques, respectively.

Results

Except for P-LCR, all the other platelet indices (PLT, MPV, PDW, and PCT) were significantly lower in the cases than the controls (P < 0.05). Also, it was observed that the level of expression of the activation markers; PAC 1 and CD62p showed a significant (P < 0.05) decreased before and after activation in falciparum malaria cases than in the controls. On the contrary, CD36 expression in the controls did not differ significantly (p > 0.05) from the malaria cases. Platelet activation markers were known to be associated with increased risk of falciparum malaria with the mean fluorescence intensity of PAC1 (Odds Ratio [OR] 34.0, Relative Risk [RR] 4.47, 95% Confidence Interval [CI] 4.904–235.7; p < 0.0001) and CD36 (OR 4.2, RR 1.82, 95% CI 0.9824–17.96; p = 0.04). Moreover, the percentage expression of CD62p (OR 4.0, RR 1.80, 95% CI 0.59–27.24; p = 0.19) was also observed to be probably associated with increased risk of falciparum malaria although not statistically significant (p > 0.05).

Conclusion

Plasmodium falciparum malaria has been known to be associated with platelet activation markers, which probably contributes to thrombocytopenia.
Literature
1.
go back to reference WHO. World malaria report. Geneva. World Health Organization. 2014. WHO. World malaria report. Geneva. World Health Organization. 2014.
2.
go back to reference Grau GE, Mackenzie CD, Carr RA. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria J Infect Dis. 2003;187:461–6.PubMed Grau GE, Mackenzie CD, Carr RA. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria J Infect Dis. 2003;187:461–6.PubMed
3.
go back to reference Chotivanich K, Sritabal J, Udomsangpetch R. Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. J Infect Dis. 2004;189:1052–5.CrossRef Chotivanich K, Sritabal J, Udomsangpetch R. Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. J Infect Dis. 2004;189:1052–5.CrossRef
4.
go back to reference Ladhani S, Lowe B, Cole AO, Kowuondo K, Newton CR. Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br J Haematol. 2002;119:839–47.CrossRef Ladhani S, Lowe B, Cole AO, Kowuondo K, Newton CR. Changes in white blood cells and platelets in children with falciparum malaria: relationship to disease outcome. Br J Haematol. 2002;119:839–47.CrossRef
5.
go back to reference Beale LS. On the germinal matter of the blood, with remarks upon the formation of fibrin. JMI. 1864;12:47–63. Beale LS. On the germinal matter of the blood, with remarks upon the formation of fibrin. JMI. 1864;12:47–63.
6.
go back to reference Skudowitz RB, Katz J, Lurie A, Levin J, Metz J. Mechanisms of thrombocytopenia in malignant tertian malaria. Br J Haematol. 1973;2:515–8. Skudowitz RB, Katz J, Lurie A, Levin J, Metz J. Mechanisms of thrombocytopenia in malignant tertian malaria. Br J Haematol. 1973;2:515–8.
7.
go back to reference Essien EM. The circulating platelet in acute malaria infection. Br J Haematol. 1989;72:589–90.CrossRef Essien EM. The circulating platelet in acute malaria infection. Br J Haematol. 1989;72:589–90.CrossRef
8.
go back to reference Wassmer SC, Taylor T, Alexander CM, Kanjala M, Mavuto MM, Molyneux ME, et al. Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria—possible modulation in vivo by thrombocytopenia. J Infect Dis. 2008;197:72–8.CrossRef Wassmer SC, Taylor T, Alexander CM, Kanjala M, Mavuto MM, Molyneux ME, et al. Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria—possible modulation in vivo by thrombocytopenia. J Infect Dis. 2008;197:72–8.CrossRef
9.
go back to reference Scott CS, Van Zyl D, Ho E, Ruivo L, Mendelow B, Coetzer TL. Thrombocytopenia in patients with malaria: automated analysis of optical platelet counts and platelet clumps with the cell Dyn CD4000 analyzers. Clin Lab Haematol J. 2002;24:295–302.CrossRef Scott CS, Van Zyl D, Ho E, Ruivo L, Mendelow B, Coetzer TL. Thrombocytopenia in patients with malaria: automated analysis of optical platelet counts and platelet clumps with the cell Dyn CD4000 analyzers. Clin Lab Haematol J. 2002;24:295–302.CrossRef
11.
go back to reference Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost. 2005;3:775–7.CrossRef Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost. 2005;3:775–7.CrossRef
12.
go back to reference Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010. A systematic analysis. Lancet. 2012;379:413–31.CrossRef Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010. A systematic analysis. Lancet. 2012;379:413–31.CrossRef
13.
go back to reference Ministry of Health (MOH). Annual report. Accra, Ghana, 2011. Ministry of Health (MOH). Annual report. Accra, Ghana, 2011.
14.
go back to reference McMorran BJ, Marshall VM, de Graaf C, Drysdale KE, Shabbar M, Smyth GK. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science. 2009;323:797–800.CrossRef McMorran BJ, Marshall VM, de Graaf C, Drysdale KE, Shabbar M, Smyth GK. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science. 2009;323:797–800.CrossRef
15.
go back to reference Peyron F, Polack B, Lamotte D, Kolodie L, Ambroise-Thomas P. Plasmodium falciparum growth inhibition by human platelets in vitro. J Parasitol. 1989;196:622–8. Peyron F, Polack B, Lamotte D, Kolodie L, Ambroise-Thomas P. Plasmodium falciparum growth inhibition by human platelets in vitro. J Parasitol. 1989;196:622–8.
16.
go back to reference Gérardin P, Rogier C, Ka AS, Jouvencel P, Brousse V, Imbert P. Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg. 2002;66:686–91.CrossRef Gérardin P, Rogier C, Ka AS, Jouvencel P, Brousse V, Imbert P. Prognostic value of thrombocytopenia in African children with falciparum malaria. Am J Trop Med Hyg. 2002;66:686–91.CrossRef
17.
go back to reference Inyang AL, Sodeinde O, Okpako DT, Essien EM. Platelet reactions after interaction with cultured Plasmodium falciparum infected erythrocytes. Br J Haematol. 1987;66:375–8.CrossRef Inyang AL, Sodeinde O, Okpako DT, Essien EM. Platelet reactions after interaction with cultured Plasmodium falciparum infected erythrocytes. Br J Haematol. 1987;66:375–8.CrossRef
18.
go back to reference Srivastava K, Cockburn IA, Swaim A, Thompson LE, Tripathi A, Fletcher CA, et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe. 2008;4:179–87.CrossRef Srivastava K, Cockburn IA, Swaim A, Thompson LE, Tripathi A, Fletcher CA, et al. Platelet factor 4 mediates inflammation in experimental cerebral malaria. Cell Host Microbe. 2008;4:179–87.CrossRef
Metadata
Title
Assessment of platelet indices and platelet activation markers in children with Plasmodium falciparum malaria
Authors
Renate Asare
Clement Opoku-Okrah
Kwabena Owusu Danquah
Ohene Opare-Sem
Otchere Addai-Mensah
Daniel Gyamfi
Francis Agyei Amponsah
Edward Y. Afriyie
Richard Vikpebah Duneeh
David Ntiamoah Ofosu
Michael Frimpong
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2020
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-020-03218-4

Other articles of this Issue 1/2020

Malaria Journal 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.